Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology

Cells
Andrew C Brane, Trygve O Tollefsbol

Abstract

Telomeres and telomerase provide a unique and important avenue of study in improving both life expectancy and quality of life due to their close association with aging and disease. While major advances in our understanding of these two biological mediators have characterized the last two decades, previous studies have been limited by the inability to affect change in real time within living cells. The last three years, however, have witnessed a huge step forward to overcome this limitation. The advent of the clustered regularly interspaced short palindromic repeats/CRISPR-associated (CRISPR/Cas) system has led to a wide array of targeted genetic studies that are already being employed to modify telomeres and telomerase, as well as the genes that affect them. In this review, we analyze studies utilizing the technology to target and modify telomeres, telomerase, and their closely associated genes. We also discuss how these studies can provide insight into the biology and mechanisms that underlie aging, cancer, and other diseases.

References

Jul 1, 1992·Experimental Gerontology·C B HarleyR C Allsopp
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R K MoyzisJ R Wu
May 1, 1982·Cell·J W Szostak, E H Blackburn
May 30, 1998·Genes & Development·C I Nugent, V Lundblad
Mar 29, 2005·Journal of Molecular Evolution·Francisco J M MojicaElena Soria
Jul 23, 2005·Science·Ignacio FloresMaría A Blasco
Aug 25, 2007·Nature Reviews. Molecular Cell Biology·Norman E Sharpless, Ronald A DePinho
Sep 29, 2011·The Journal of Experimental Medicine·Camille LobryIannis Aifantis
Jan 5, 2013·Science·Prashant MaliGeorge M Church
May 8, 2013·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Jing GeBevin P Engelward
Sep 17, 2014·Genes & Development·Falong LuYi Zhang
Oct 2, 2014·The Journal of Clinical Investigation·Rajat M Gupta, Kiran Musunuru
Dec 31, 2014·Naunyn-Schmiedeberg's Archives of Pharmacology·Anirban Kar, Shantanu Chowdhury
Jul 22, 2015·ELife·Kunitoshi ChibaDirk Hockemeyer
Sep 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Wulan DengRobert H Singer
Dec 22, 2015·Cell·John MaciejowskiTitia de Lange
Jan 21, 2016·PLoS Genetics·Madalena C CarneiroMiguel Godinho Ferreira
May 28, 2016·RNA Biology·Albert JeltschMark Helm
Aug 12, 2016·Science Translational Medicine·Susan E StanleyMary Armanios
Nov 4, 2016·Cancer Discovery·Semih Can AkıncılarVinay Tergaonkar
Mar 4, 2017·The Journal of Cell Biology·Paula Martínez, Maria A Blasco
May 17, 2017·The Plant Journal : for Cell and Molecular Biology·Steven DreissigAndreas Houben
May 27, 2017·Journal of Molecular Histology·Shuxian Zhang, Zhan Song
Jul 22, 2017·Neoplasia : an International Journal for Oncology Research·Darshan S ChandrashekarSooryanarayana Varambally
Oct 4, 2017·International Journal of Molecular Sciences·Hyojung KimYunjong Lee
Oct 23, 2017·Redox Biology·José Santiago Ibáñez-CabellosFederico V Pallardó
Dec 14, 2017·Nature Communications·Kate BeishlinePaul M Lieberman
Feb 2, 2018·Molecular Biology of the Cell·Jens C SchmidtThomas R Cech
Apr 27, 2018·Nature·Thi Hoang Duong NguyenKathleen Collins

❮ Previous
Next ❯

Citations

Jan 23, 2020·International Journal of Molecular Sciences·Luan WenJie Xu
Oct 31, 2019·The Journal of International Medical Research·Pan LiuLina Ma
Jan 17, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael Fossel
Apr 1, 2020·Indian Journal of Clinical Biochemistry : IJCB·Rajendra PrasadWajid Mohammad
Feb 3, 2021·Cancer Treatment and Research Communications·Ali Salimi-JedaAsghar Abdoli

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.